Mayo Clinic Picks Complete Genomics for Whole Genome Sequencing

The Mayo Clinic’s Center for Individualized Medicine has chosen Complete Genomics Inc. (NASDAQ:GNOM) as its provider of outsourced whole human genome sequencing, MarketWatch reports. The move will enable Mayo Clinic researchers to use Complete Genomics’ sequencing service for large-scale projects.

The Center for Individualized Medicine already operates a comprehensive sequencing laboratory in its Medical Genome Facility, but under the terms of the agreement, it can also send genetic material to Complete Genomics for analysis and sequencing, MarketWatch said. Financial details of the agreement were not disclosed.

Outsourced projects will be coordinated with the Center of Individualized Medicine’s Medical Genome Facility to help accelerate Mayo Clinic’s translational genomics-based programs. Mayo Clinic plans to use these initiatives to determine best practices for applying genetic information to patient care, according to the report.

The Mayo Clinic’s Center for Individualized Medicine is already engaged in “several high-impact genome- and epigenome-based studies”  in individualized care, according to Dr. Gianrico Farrugia, director of Mayo Clinic’s Center for Individualized Medicine. “Access to quality whole genome sequencing services can only expedite our efforts to improve care for all of our patients with new individualized medicine tools and techniques,” Farrugia said.

There is a growing trend in medicine to collect and study genetic information from consenting patients to improve medical care in everything from cancer diagnosis and treatment to drug therapy and disease prevention. Doctors could also use information provided by genome sequencing to give patients a heads up about things they can do to prevent or delay the onset of disease.

To contact the reporter on this story: Gina Smith at

To contact the editor responsible for this story: Damien Hoffman at